VERONICA BASS: Open Payments
NPI 1538730494 · FORT PIERCE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $101 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $255 |
| Calliditas Therapeutics US Inc. | 1 | $150 |
| Lilly USA, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $23 |
| Vantive US Healthcare LLC | 1 | $23 |
| AKEBIA THERAPEUTICS INC | 1 | $21 |
Products named: Kerendia, TARPEYO, JARDIANCE, VOYXACT, FARXIGA, ACTHAR, IBSRELA, Renal - PD.
Industry payments across FL — which companies pay providers there.
